Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1267191.RApGUgdqXMi1Hcr7FH_Y6LRHbclJsA3dBGWRcqQRW7_BM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1267191.RApGUgdqXMi1Hcr7FH_Y6LRHbclJsA3dBGWRcqQRW7_BM130_assertion type Assertion NP1267191.RApGUgdqXMi1Hcr7FH_Y6LRHbclJsA3dBGWRcqQRW7_BM130_head.
- NP1267191.RApGUgdqXMi1Hcr7FH_Y6LRHbclJsA3dBGWRcqQRW7_BM130_assertion description "[The O6-methylguanine-DNAmethyltransferase (MGMT) promoter methylation and 1p19q codeletion status can predict sensitivity to chemotherapy and radiation in low- and intermediate-grade gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267191.RApGUgdqXMi1Hcr7FH_Y6LRHbclJsA3dBGWRcqQRW7_BM130_provenance.
- NP1267191.RApGUgdqXMi1Hcr7FH_Y6LRHbclJsA3dBGWRcqQRW7_BM130_assertion evidence source_evidence_literature NP1267191.RApGUgdqXMi1Hcr7FH_Y6LRHbclJsA3dBGWRcqQRW7_BM130_provenance.
- NP1267191.RApGUgdqXMi1Hcr7FH_Y6LRHbclJsA3dBGWRcqQRW7_BM130_assertion SIO_000772 25727224 NP1267191.RApGUgdqXMi1Hcr7FH_Y6LRHbclJsA3dBGWRcqQRW7_BM130_provenance.
- NP1267191.RApGUgdqXMi1Hcr7FH_Y6LRHbclJsA3dBGWRcqQRW7_BM130_assertion wasDerivedFrom befree-2016 NP1267191.RApGUgdqXMi1Hcr7FH_Y6LRHbclJsA3dBGWRcqQRW7_BM130_provenance.
- NP1267191.RApGUgdqXMi1Hcr7FH_Y6LRHbclJsA3dBGWRcqQRW7_BM130_assertion wasGeneratedBy ECO_0000203 NP1267191.RApGUgdqXMi1Hcr7FH_Y6LRHbclJsA3dBGWRcqQRW7_BM130_provenance.